Gene One Life Science Inc
KRX:011000
Gene One Life Science Inc
KRX:011000
Price:
1 476
KRW
-6.58%
Market Closed
Market Cap:
₩126.1B
Relative Value
The Relative Value of one
Gene One Life Science Inc
stock under the Base Case scenario is
hidden
KRW.
Compared to the current market price of 1 476 KRW,
Gene One Life Science Inc
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Gene One Life Science Inc Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
Gene One Life Science Inc Competitors
Gene One Life Science Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| KR |
|
Gene One Life Science Inc
KRX:011000
|
125.8B KRW | 4.1 | -2.4 | -6.7 | -3.7 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 643 258.8 | -159 901.4 | -194 171.3 | -191 955.6 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
406.8B USD | 6.8 | 172.2 | 16.6 | 23.6 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
202B USD | 5.5 | 26.2 | 15 | 15 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
189B USD | 6.4 | 22 | 14.9 | 14.9 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
121.1B USD | 10.2 | 30.9 | 23.6 | 24.6 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 094 | -534.3 | -581.8 | -566.3 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.4B USD | 5.8 | 18.3 | 13.9 | 15.8 | |
| NL |
|
argenx SE
XBRU:ARGX
|
42.9B EUR | 14.2 | 33.4 | 57.3 | 58.9 | |
| AU |
|
CSL Ltd
ASX:CSL
|
71.4B AUD | 3.2 | 16.5 | 11.4 | 14.2 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.2 | -61.8 | -66.7 | -60.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
